LISA GRAVES-AUSTIN: Open Payments
NPI 1508804634 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,273 in 114 payments from 23 companies in 2025. Trend: 2023 $120 · 2024 $927 · 2025 $2,273
Food & beverage: $2,273
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $422 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $316 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $166 |
| Amgen Inc. | 12 | $153 |
| Novo Nordisk Inc | 11 | $151 |
| ABBVIE INC. | 11 | $150 |
| Lilly USA, LLC | 9 | $132 |
| PFIZER INC. | 6 | $106 |
| Axsome Therapeutics, Inc. | 4 | $95 |
| Lundbeck LLC | 4 | $91 |
Products named: AIRSUPRA, CAPLYTA, REXULTI, VRAYLAR, MOUNJARO, Auvelity, Ozempic, JARDIANCE.
Industry payments across OH — which companies pay providers there.
